RESEARCH TRIANGLE PARK, N.C. – October 19, 2011 – Quintiles today announced the acquisition of VCG & Associates and VCG BIO, based in Holliston, Mass., and Cave Creek, Ariz., respectively. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
VCG develops strategic healthcare marketing initiatives to address the challenges surrounding U.S. pharmaceutical market entry. It focuses on biopharma companies that need supplemental resources to maximize commercial opportunities. VCG brings experience in the areas of market access, distribution and reimbursement implementation.
“VCG complements our solutions and capabilities within both our Commercial and Consulting divisions with emerging biopharma, companies looking to establish a commercial presence in the U.S., and drug development companies entering the commercial space for the first time,” said Rich Pilnik, President, Global Commercial Solutions. “By creating virtual companies – utilizing market access services, proven distribution channels and reimbursement strategies – biopharma can bring needed therapies to market faster and more efficiently.”
VCG has experience across numerous therapeutic areas and device markets, contacts throughout the healthcare industry, access to managed care organizations and government payers, and special services with distribution and pricing analysis for commercial entry.
“Our team is very excited to join Quintiles,” VCG Co-Founder and Managing Partner Brad Fleahman said. “We have worked closely with Quintiles for the past several years, and this acquisition is a natural step that allows both organizations to serve our customers with specialized commercialization offerings. VCG will continue to provide our customers the same high level of service from our talented employees and trusted business operations and processes, while drawing upon Quintiles’ complementary expertise and services.”
About Global Commercial Solutions
With more than 10,000 employees in 30 countries, the Commercial group leverages the full suite of Quintiles’ sales, marketing, clinical, consulting and capital services to provide innovative, customized commercial solutions to partners throughout the biopharmaceutical industry. Global Commercial Solutions was formerly Innovex, which now functions solely under the Quintiles name. For more information, please visit www.quintiles.com/commercial-services.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
VCG is a privately held Massachusetts-based company, specializing in partnerships with pharmaceutical, biotechnology, and other life sciences companies to augment their commercial success. VCG focuses specifically on Commercial and Government Managed Care strategy consulting and account management implementation outsourcing services. With experience in launching more than 40 products in therapeutic categories such as ophthalmology, oncology, pain management, cardiovascular, dermatology, plasma derivatives, psychiatric, and more, VCG has a proven track record. VCG supports companies with their distribution and reimbursement requirements. With senior-level, hands-on operating experience and deep industry knowledge, VCG is uniquely capable of delivering the strategic insights and implementation capabilities that drive client success in the Supply Chain, Managed Care and Government markets. For more information, please visit www.vcgassociates.com or www.vcgbio.com.